Ghaith Bakdash, Director Cell Biology at Microbiotica, during the Microbiome Connect: Europe 2022 described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.